Skip to main content
SpringerLink
Log in

Sulindac and polyp regression

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Waddell WR, Loughry RW: Sulindac for polyposis of the colon. J Surg Oncol 24: 83–87, 1983

    Google Scholar 

  2. Nonsteroidal anti-inflammatory agents.In: Mc Evoy G (ed) AHFS Drug Information. The American Society of Hospital Pharmacists, Inc., Bethesda MD, 1993, pp 1201–1205

    Google Scholar 

  3. Brooks PM, Wood AJJ: Nonsteroidal antiinflammatory drugs-differences and similarities. N Engl J Med 324: 1716, 1991

    Google Scholar 

  4. Hucker HB, StauffeSr C, White SD, Rhodes RE, Arison BH, Umbenhauer ER, Bower RJ, McMahon FG: Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)-benzylidenyl]-indene-3-acetic acid in the rat, dog, rhesus monkey, and man. Drug Metabolism and Disposition 1: 721–736, 1973

    Google Scholar 

  5. Duggan DE, Hooke KF, Risley EA, Shen TY, Van Arman CG: Identification of the biologically active form of sulindac. J Pharmacol Exp Ther 201: 8–13, 1977

    Google Scholar 

  6. Shen TY, Winter CA: Chemical and biological studies on indomethacin, sulindac and their analogs. Adv Drug Res 12: 89–245, 1977

    Google Scholar 

  7. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P, Markham A, Krush AJ, Petersen G, Hamilton SR, Nibert MC, Levy DB, Bryan TM, Preisinger AC, Smith KJ, Su LK, Kinzler KW, Vogelstein B: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665–669

    Google Scholar 

  8. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, Mckechnie D, Finniear R, Markham A, Groffen J, Bogushki MS, Altschul SF, Horri A, Ando H, Miyoshi Y, Miki Y, Nishisho I, Nakamura Y: Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661–665

    Google Scholar 

  9. Bussey HJR: Familial polyposis coli. Family studies, histopathology, differential diagnosis, and results of treatment. Baltimore, MD: Johns Hopkins University Press, 1975

    Google Scholar 

  10. Gardner EJ, Richards RC: Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 1953; 5: 139

    Google Scholar 

  11. Pollard M, Luckert PH: Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treat Rep 1980; 64: 1323–1327

    Google Scholar 

  12. Pollard M, Luckert PH: Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science 1981; 214: 558–559

    Google Scholar 

  13. Pollard M, Luckert PH, Schmidt MA: The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat. Cancer Lett 1983; 21: 57–61

    Google Scholar 

  14. Narisawa T, Sato M, Sano M, Takahashi T: Inhibition of development of methylnitrosourea-induced rat colonic tumors by peroral administration of indomethacin. Gann 1982; 73: 377–381

    Google Scholar 

  15. Narisawa T, Sato M, Tani M, Kudo T, Takahashi T, Goto A: Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Research 1981; 41: 1954–1957

    Google Scholar 

  16. Ross DS, Bitzer D, Roy T, Murphy JE: Piroxicam inhibits the growth of an adenocarcinoma isograft in Fischer rats. J Surg Res 1988; 45: 249–253

    Google Scholar 

  17. McCormick DL, Madigan MJ, Moon RC: Modulation of rat mammary carcinogenesis by indomethacin. Cancer Res 1985; 45: 1803–1808

    Google Scholar 

  18. Moorghen M, Ince P, Finney KJ, Sunter JP, Appleton DR, Watson AJ: A protective effect of sulindac against chemically-induced primary colonic tumors in mice. J Pathol 1988; 156: 341–347

    Google Scholar 

  19. Skinner SA, Penney AG, O'Brien PE: Sulindac inhibits the rate of growth and appearance of colon tumors in the rat. Arch Surg 1991; 126: 1094–1096

    Google Scholar 

  20. Waddell WR, Gerner RE: Indomethacin and ascorbate inhibit desmoid tumors. J Surg Oncol 1980; 15: 85–90

    Google Scholar 

  21. Waddell WR, Gerner RE, Reich MP: Nonsteroidal anti-inflammatory drugs and tamoxifen for desmoid tumors and carcinoma of stomach. J Surg Oncol 1983; 22: 197–211

    Google Scholar 

  22. Gonzaga RAF, Lima FR, Carneiro S, Maciel J, Junior MA: Sulindac treatment for familial polyposis. Lancet 1985; 1: 751

    Google Scholar 

  23. Labayle D, Fischer D, Hagege JP: Efficacité du sulindac dans le traitement de la polypose rectocolique. Gastroenterol Clin Biol 1986; 10: 436

    Google Scholar 

  24. Waddell WR, Ganser GF, Cerise EJ, Loughry RW: Sulindac for polyposis of the colon. Am J Surg 1989; 157: 175–179

    Google Scholar 

  25. Charneau J, D'Aubigny N, Burtin P, Person B, Boyer J: Micropolypes rectaux après colectomie totale pour polypose familiale: Efficacité du sulindac. Gastroenterol Clin Bio 1990; 14: 153–157

    Google Scholar 

  26. Rigau J, Pique JM, Rubio E, Planas R, Tarrech JM, Bordas J: Effects of long-term sulindac therapy on colonic polyposis. Ann Intern Med 1991; 115: 952–954

    Google Scholar 

  27. Hixson LJ, Earnest DL, Fennerty MB, Sampliner RE: NSAID effect on sporadic colon polyps. Am J Gastroenterol 1993; 88: 1652–1656

    Google Scholar 

  28. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, Duhamel O, Trousset M, Attali P: Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterol 1991; 101: 635–639

    Google Scholar 

  29. Nugent KP, Farmer KCR, Spigelman AD, Williams DB, Phillips RKS: Randomized controlled clinical trial of sulindac on intestinal polyposis in FAP. Gut

  30. Parker AL, Kadakia SC, Maccini DM, Cassaday MA, Angueira C: Disappearance of duodenal polyps in Gardner's syndrome with sulindac treatment. Am J Gastroenterol 1993; 88: 93–94

    Google Scholar 

  31. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJA: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 398: 1313–1316

    Google Scholar 

  32. Winde G, Gumbinger HG, Osswald H, Kemper F, Bunte H: The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration. Int J Color Dis 1993; 8: 13–17

    Google Scholar 

  33. Waddell W: The effect of sulindac on colon polyps: Circumvention of a transformed phenotype - A hypothesis. J Surg Oncology 1994; 55: 52–55

    Google Scholar 

  34. Spagnesi MT, Tonelli F, Dolara P, Caderni G, Valanzano R, Anastasi A, Bianchini F: Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment. Gastroenterol 1994; 106: 362–366

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Johns Hopkins University School of Medicine, Blalock 935, The Johns Hopkins Hospital, 600 North Wolfe Street, 21287-4461, Baltimore, Maryland, USA

    Francis M. Giardiello

Authors
  1. Francis M. Giardiello
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giardiello, F.M. Sulindac and polyp regression. Cancer Metast Rev 13, 279–283 (1994). https://doi.org/10.1007/BF00666098

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00666098

Key words

Search

Navigation